• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
Asian Pacific Journal of Cancer Prevention
Articles in Press
Current Issue
Journal Archive
Volume Volume 19 (2018)
Volume Volume 18 (2017)
Volume Volume 17 (2016)
Issue Issue 12
Issue Issue 11
Issue Issue 10
Issue Issue 9
Issue Issue 8
Issue Issue 6
Issue Issue 7
Issue S3
Issue S2
Issue S1
Issue Issue 5
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 16 (2015)
Volume Volume 15 (2014)
Volume Volume 14 (2013)
Volume Volume 13 (2012)
Volume Volume 12 (2011)
Volume Volume 11 (2010)
Volume Volume 10 (2009)
Volume Volume 9 (2008)
Volume Volume 8 (2007)
Volume Volume 7 (2006)
Volume Volume 6 (2005)
Volume Volume 5 (2004)
Volume Volume 4 (2003)
Volume Volume 3 (2002)
Volume Volume 2 (2001)
Volume Volume 1 (2000)
Liu, A., Liao, H., Li, Z., Liu, J., Zhou, C., Guo, Z., Xie, H., Peng, C. (2016). New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian Cancer. Asian Pacific Journal of Cancer Prevention, 17(12), 5087-5094. doi: 10.22034/APJCP.2016.17.12.5087
Ai Ling Liu; Hong Qing Liao; Zhi Liang Li; Jun Liu; Cui Lan Zhou; Zi Fen Guo; Hong Yan Xie; Cui Ying Peng. "New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian Cancer". Asian Pacific Journal of Cancer Prevention, 17, 12, 2016, 5087-5094. doi: 10.22034/APJCP.2016.17.12.5087
Liu, A., Liao, H., Li, Z., Liu, J., Zhou, C., Guo, Z., Xie, H., Peng, C. (2016). 'New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian Cancer', Asian Pacific Journal of Cancer Prevention, 17(12), pp. 5087-5094. doi: 10.22034/APJCP.2016.17.12.5087
Liu, A., Liao, H., Li, Z., Liu, J., Zhou, C., Guo, Z., Xie, H., Peng, C. New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian Cancer. Asian Pacific Journal of Cancer Prevention, 2016; 17(12): 5087-5094. doi: 10.22034/APJCP.2016.17.12.5087

New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian Cancer

Article 7, Volume 17, Issue 12, December 2016, Page 5087-5094  XML PDF (311 K)
Document Type: Research Articles
DOI: 10.22034/APJCP.2016.17.12.5087
Authors
Ai Ling Liu1; Hong Qing Liao2; Zhi Liang Li3; Jun Liu4; Cui Lan Zhou5; Zi Fen Guo6; Hong Yan Xie7; Cui Ying Peng 8
1Institude of Biology, School of Pharmaceutical and Biological Science, University of south China
2Reproductive Health Hospital of Nanhua-Xinghui in Hengyang City, Heng Yang 421001, Hunan Province, China.
3Institute of Biological Science, The Key Laboratory of Biological Toxicology and Ecological Restoration of Hengyang City, School of Pharmaceutical and Biological Science, China.
4Institute of Biological Science, The Key Laboratory of Biological Toxicology and Ecological Restoration of Hengyang City, School of Pharmaceutical and Biological Science,China
5Department of Anatomy, University of South China, Heng Yang 421001, Hunan Province, China
6Institute of Pharmacy and Pharmacology, University of South China, China
7Institute of Biological Science, The Key Laboratory of Biological Toxicology and Ecological Restoration of Hengyang City, School of Pharmaceutical and Biological Science, China
8Institute of Biology, School of Pharmaceutical and Biological Science, University of South China
Receive Date: 09 October 2016,  Revise Date: 14 December 2016,  Accept Date: 16 January 2017 
Abstract
 
mTOR, the mammalian target of rapamycin, is a conserved serine/threonine kinase which belongs to the phosphatidyl-linositol kinase-related kinase (PIKK) family. It has two complexes called mTORC1 and mTORC2. It is well established that mTOR plays important roles in cell growth, proliferation and differentiation. Over-activation of the mTOR pathway is considered to have a relationship with the development of many types of diseases, including polycystic ovary syndrome (PCOS) and ovarian cancer (OC). mTOR pathway inhibitors, such as rapamycin and its derivatives, can directly or indirectly treat or relieve the symptoms of patients suffering from PCOS or OC. Moreover, mTOR inhibitors in combination with other chemical-molecular agents may have extraordinary efficacy. This paper will discuss links between mTOR signaling and PCOS and OC, and explore the mechanisms of mTOR inhibitors in treating these two diseases, with conclusions regarding the most effective therapeutic approaches.
Keywords
mTOR signaling pathway; PCOS; Ovarian cancer
Statistics
Article View: 521
PDF Download: 618
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

 



 

Journal Management System. Designed by sinaweb.